Literature DB >> 28856539

Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda.

Stephen B Asiimwe1,2, Robin Fatch3, Gregory Patts4,5, Michael Winter5, Christine Lloyd-Travaglini4,5, Nneka Emenyonu3, Winnie Muyindike6, Allen Kekibiina6, Elena Blokhina5, Natalia Gnatienko4, Evgeny Kruptisky7,8, Debbie M Cheng4, Jeffrey H Samet9,10, Judith A Hahn11,3.   

Abstract

In HIV-infected drinkers, alcohol types more likely to cause inflammation could plausibly increase the risk of HIV disease progression. We therefore assessed the association between alcohol type and plasma HIV RNA level (HIV viral load) among HIV-infected drinkers not on antiretroviral therapy (ART) in Russia and Uganda. We analyzed the data of participants from cohorts in Russia and Uganda and assessed their HIV viral load at enrollment by the alcohol type predominantly consumed. We defined predominant alcohol type as the alcohol type contributing >50% of total alcohol consumption in the 1 month (Russia) or 3 months (Uganda) prior to enrollment. Using multiple linear regression, we compared log10 HIV viral load by predominant alcohol type, controlling for age, gender, socioeconomic status, total number of standard drinks, frequency of drinking ≥6 drinks/occasion, and in Russia, history of injection drug use. Most participants (99.2% of 261 in Russia and 98.9% of 352 in Uganda) predominantly drank one alcohol type. In Russia, we did not find evidence for differences in viral load levels between drinkers of fortified wine (n = 5) or hard liquor (n = 49), compared to drinkers of beer/low-ethanol-content cocktails (n = 163); however, wine/high-ethanol-content cocktail drinkers (n = 42) had higher mean log10 viral load than beer/low-ethanol-content cocktail drinkers (β = 0.38, 95% CI 0.07-0.69; p = 0.02). In Uganda, we did not find evidence for differences in viral load levels between drinkers of locally-brewed beer (n = 41), commercially-distilled spirits (n = 38), or locally-distilled spirits (n = 43), compared to drinkers of commercially-made beer (n = 218); however, wine drinkers (n = 8) had lower mean log10 HIV viral load (β = -0.65, 95% CI -1.36 to 0.07, p = 0.08), although this did not reach statistical significance. Among HIV-infected drinkers not yet on ART in Russia and Uganda, we observed an association between the alcohol type predominantly consumed and the HIV viral load level in the Russia sample. These exploratory results suggest that, in addition to total number of drinks and drinking patterns, alcohol type might be a dimension of alcohol use that merits examination in studies of HIV and alcohol related outcomes.

Entities:  

Keywords:  Alcohol types; HIV viral load; HIV-disease progression; HIV-infected patients; Russia; Uganda

Mesh:

Substances:

Year:  2017        PMID: 28856539      PMCID: PMC5660666          DOI: 10.1007/s10461-017-1895-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  37 in total

Review 1.  Role of inflammation in HIV-1 disease progression and prognosis.

Authors:  Hayley Ipp; Annalise E Zemlin; Rajiv T Erasmus; Richard H Glashoff
Journal:  Crit Rev Clin Lab Sci       Date:  2014-01-30       Impact factor: 6.250

2.  Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan Africa.

Authors:  Stephen B Asiimwe; Robin Fatch; Nneka I Emenyonu; Winnie R Muyindike; Allen Kekibiina; Glenn-Milo Santos; Thomas K Greenfield; Judith A Hahn
Journal:  Alcohol Clin Exp Res       Date:  2015-07-04       Impact factor: 3.455

3.  Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development.

Authors:  Daniela Palmieri; Bianca Pane; Chiara Barisione; Giovanni Spinella; Silvano Garibaldi; Giorgio Ghigliotti; Claudio Brunelli; Ezio Fulcheri; Domenico Palombo
Journal:  J Surg Res       Date:  2011-08-24       Impact factor: 2.192

4.  Ways of measuring drinking patterns and the difference they make: experience with graduated frequencies.

Authors:  T K Greenfield
Journal:  J Subst Abuse       Date:  2000

Review 5.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

6.  Sensation seeking and alcohol use predict HIV transmission risks: prospective study of sexually transmitted infection clinic patients, Cape Town, South Africa.

Authors:  Seth C Kalichman; Leickness Simbayi; Sean Jooste; Redwaan Vermaak; Demetria Cain
Journal:  Addict Behav       Date:  2008-08-03       Impact factor: 3.913

7.  Beverage preferences and associated drinking patterns, consequences and other substance use behaviours.

Authors:  Michelle Dey; Gerhard Gmel; Joseph Studer; Petra Dermota; Meichun Mohler-Kuo
Journal:  Eur J Public Health       Date:  2013-08-12       Impact factor: 3.367

8.  Self-Report of Alcohol Use Increases When Specimens for Alcohol Biomarkers Are Collected in Persons With HIV in Uganda.

Authors:  Judith A Hahn; Robin Fatch; Jane Kabami; Bernard Mayanja; Nneka I Emenyonu; Jeffrey Martin; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

9.  Interaction of ethanol with biological membranes: the formation of non-bilayer structures within the membrane interior and their significance.

Authors:  Andrey A Gurtovenko; Jamshed Anwar
Journal:  J Phys Chem B       Date:  2009-02-19       Impact factor: 2.991

10.  Qualitative study of changes in alcohol use among HIV-infected adults entering care and treatment for HIV/AIDS in rural southwest Uganda.

Authors:  Radhika Sundararajan; Monique A Wyatt; Sarah Woolf-King; Emily E Pisarski; Nneka Emenyonu; Winnie R Muyindike; Judith A Hahn; Norma C Ware
Journal:  AIDS Behav       Date:  2015-04
View more
  2 in total

1.  Situational and motivational factors associated with unhealthy alcohol use among Russian women with HIV and hepatitis C Virus co-infection.

Authors:  N B Khalezova; A Capasso; E V Boeva; L V Gutova; V V Rassokhin; N G Neznanov; N A Belyakov; J L Brown; R J DiClemente
Journal:  Drug Alcohol Depend Rep       Date:  2022-04-14

Review 2.  Alcohol Use and the Risk of Communicable Diseases.

Authors:  Neo K Morojele; Sheela V Shenoi; Paul A Shuper; Ronald Scott Braithwaite; Jürgen Rehm
Journal:  Nutrients       Date:  2021-09-23       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.